GlassScriptPhysician profile
Kenneth Tran
NPI 1376907741
$64,976.54
in general payments reported to CMS, 2019-2025
16 companies · $39K in 2025
The $39K reported for 2025 was more than what 97% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $18.00 · 2021: $41.08 · 2022: $170 · 2023: $2,735 · 2024: $22K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Food and Beverage: $17K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,150 · Travel and Lodging: $3,112 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,225.00 |
| Food and Beverage | $17,036.57 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,150.00 |
| Travel and Lodging | $3,112.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,060.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $42,528.05 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $8,307.28 | 2025 | General - Therapies, Eluvia, General - Vascular Intervention |
| Cook Medical LLC | $4,220.95 | 2023-2025 | Zenith Alpha, Zenith, Cook |
| Cook Incorporated | $3,251.56 | 2024-2025 | Zilver Ptx, Zenith Alpha |
| W. L. Gore & Associates, INC. | $3,079.23 | 2023-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Penumbra, INC. | $1,032.09 | 2023-2025 | Indigo System, Penumbra System |
| Abbott Laboratories | $879.28 | 2019-2025 | Diamondback Peripheral, Esprit, Jeti Peripheral Catheter |
| Cagent Vascular INC | $462.26 | 2023-2025 | Serrantor |
| Philips North America LLC | $349.82 | 2022-2024 | (6554) Peripheral Vascular Undivided, (Dd1) Duo Hybrid, (6371) Laser Cvx300 |
| Medtronic, INC. | $330.98 | 2023-2025 | Endurant Iis, In.Pact Admiral, Heli-Fx Endoanchor System |
| Bard Peripheral Vascular, INC. | $116.39 | 2022 | |
| Lemaitre Vascular, INC. | $104.95 | 2023-2025 | Artegraft Vascular Graft, Xenosure Biologic Patch, Hydro Lemaitre Valvulotome |
| Veryan Medical Incorporated | $93.78 | 2023 | Biomimics 3d Vascular Stent System |
| Silk Road Medical, INC. | $92.03 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Edwards Lifesciences Corporation | $82.49 | 2021-2024 | Sapien 3 Ultra Resilia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $45.40 | 2023-2024 | Navicross |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.